Ms. Amy Christenholz, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13479 N County Road 300e, Humboldt, IL 61931 Phone: 217-259-5802 |
News Archive
Burns can be among the most devastating of injuries. Following the formulation of practice guidelines (PGs) that addressed the care and management of burn injuries in developed countries, the International Society for Burn Injuries has updated these recommendations to guide the improvement of care of burn patients in resource-limited settings (RLS).
As millions of Americans with diabetes are making New Year's resolutions to eat better and exercise, there is one organization focused on an often ignored area of treatment: the emotional and psychological issues surrounding both type 1 and type 2 diabetes.
Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.
Pfizer Inc. commented on an abstract concerning the ORAL Sync Phase 3 study of tofacitinib in patients with rheumatoid arthritis which has been posted for the European League Against Rheumatism conference.
Though there is "significant risk" of a resurgence of polio in 2013, a new report from the Independent Monitoring Board (IMB) of the Global Polio Eradication Initiative (GPEI) is optimistic about the eradication of the disease, noting that 99.9 percent of polio has been stopped worldwide, with 175 cases reported so far in 2012 compared with 350,000 reported in 1988, BBC News reports.
› Verified 5 days ago